ZZBiotics creates genetically engineered probiotic supplements designed to break down acetaldehyde, a toxic byproduct of alcohol consumption. The product is taken as a probiotic pill that works in the gut to neutralize acetaldehyde after drinking, helping reduce hangover symptoms. It is sold directly to consumers via its website, with options for one-time purchases or subscriptions. ZBiotics differentiates itself by a clear, people-first approach and ongoing research into other health challenges (dairy intolerance, radiation exposure, lead contamination in water), alongside a commitment to transparency. The company’s goal is to help people manage the after-effects of alcohol while expanding probiotic science and exploring solutions for other health issues.
Work here?Claim your company
Industries
Company Size
51-200
Company Stage
Series A
Total Funding
$14.4M
Headquarters
San Francisco, California
Founded
2016
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$14.4M
Below
Industry Average
Funded Over
3 Rounds
Industry standards
ZBiotics floor display wins Silver OMA. OMA Silver Award International partnered with ZBiotics to support its transition from a fast-growing direct-to-consumer brand into brick-and-mortar retail with a bold, modern floor display built to stand out in highly competitive store environments. Program Objective After gaining momentum as a direct-to-consumer brand starting in 2019, ZBiotics identified brick-and-mortar expansion as a strategic priority in early 2024. Entering convenience and liquor channels introduced a clear challenge: winning attention in crowded aisles where space is limited and visual competition is high. The objective was straightforward: create a compact, modern floor display that commands attention while preserving valuable floor space. The solution needed to be... Sources include: Great Northern instore
“When I started ZBiotics, I was sure somebody would beat us to the punch,” says Dr. Zack Abbott, the microbiologist behind a genetically engineered probiotic serving as a hangover remedy that many consumers now swear by. “But when we launched three years later, we were the first to market with a genetically engineered probiotic [ZBiotics Pre-alcohol: a shot containing bacteria engineered to expresses an enzyme that breaks down a toxic byproduct of alcohol in the gut]. “Five years later, we launched our second product [ZBiotics Sugar-to-Fiber: which contains containing bacteria engineered to express an enzyme that converts sugars into fibers in the gut] and still nobody else had launched a GM probiotic. I’m not totally sure why, I think maybe there’s a fear that consumers will reject it, but we just haven’t seen that
Biotechnology company Zbiotics has announced the launch of Sugar-to-Fiber Probiotic Drink Mix, which it claims to be the first product of its kind to hit the consumer market.
ZBiotics, the pioneers carving a new category of genetically engineered probiotics, today announced the close of its $12M Series A funding round, led
ZBiotics raises $12M in Series A funding.
Find jobs on Simplify and start your career today
Industries
Company Size
51-200
Company Stage
Series A
Total Funding
$14.4M
Headquarters
San Francisco, California
Founded
2016
Find jobs on Simplify and start your career today